CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Activity

22 hedge funds and large institutions have $1.17M invested in COSCIENS Biopharma Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
2
Closed
5
Calls
$14K
Puts
$26K
Net Calls
-$12K
Net Calls Change
-$1K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$656K
2
VF
2
Virtu Financial
New York
$44K
3
Citadel Advisors
3
Citadel Advisors
Florida
$29K
4
UBS Group
4
UBS Group
Switzerland
$24K
5
ARTA
5
A.R.T. Advisors
New York
$19K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$44K
2
Millennium Management
2
Millennium Management
New York
$0
3
CG
3
Cutler Group
California
$0
4
FDCDDQ
4
Federation des caisses Desjardins du Quebec
Quebec, Canada
$57.7K
Name Market Value Shares Shares
Change 		Shares
Change %
Group One Trading
26
Group One Trading
Illinois
– – – –
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
Simplex Trading
28
Simplex Trading
Illinois
– – – –
SPIA
29
Steward Partners Investment Advisory
New York
$0 4 – –
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$0 45 +1 +2%
1
2